Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension
Introduction Whether ACE inhibitors (ACEi) or angiotensin II receptor blocker (ARB) therapy should be continued, initiated or ceased in patients with COVID-19 is uncertain. Given the widespread use of ACEi/ARBs worldwide, guidance on the use of these drugs is urgently needed. This prospective meta-a...
Saved in:
| Main Authors: | Anthony Rodgers, George Stergiou, Bryan Williams, Sonali Rukshana Gnanenthiran, Markus P Schlaich, Claudio Borghi, Dylan Burger, Fadi Charchar, Neil R Poulter, Ulrike Muscha Steckelings, Maciej Tomaszewski, Thomas Unger, Richard D Wainford, Aletta E Schutte |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/2/e043625.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECTS OF VITAMIN D ON THE RENIN-ANGIOTENSIN SYSTEM
by: L. Pashova-Stoyanova, et al.
Published: (2019-09-01) -
RENIN-ANGIOTENSIN SYSTEM ROLE IN ARTERIAL HYPERTENSION DEVELOPMENT
by: I. N. Medvedev, et al.
Published: (2009-08-01) -
The renin-angiotensin system in healthy human platelets: expressed but inactive
by: François Panosetti, et al.
Published: (2025-12-01) -
THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01) -
Renin-Angiotensin System Induced Secondary Hypertension: The Alteration of Kidney Function and Structure
by: Zahra Pezeshki, et al.
Published: (2021-01-01)